Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy

Brain Research

Volumn 1022, Issue 1-2, 2004, Pages 71-80

  Chartoff, Elena H ^a   Szczypka, Mark S ^b   Palmiter, Richard D ^c,d   Dorsa, Daniel M ^e  

^a MCLEAN HOSPITAL   (United States)

^b Nephros Therapeutics Inc   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Dopamine deficient mouse; l DOPA; Microinjection; Neuropeptide; SR 48692; Striatum

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CARBIDOPA PLUS LEVODOPA; DOPAMINE; MESSENGER RNA; NEUROTENSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIVITY; FEMALE; HYPERACTIVITY; MALE; MOTOR PERFORMANCE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECIES COMPARISON; STEREOTYPY; SURVIVAL TIME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; CARBIDOPA; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DOPAMINE BETA-HYDROXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; HALOPERIDOL; IN SITU HYBRIDIZATION; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; NEUROTENSIN; PYRAZOLES; QUINOLINES; RECEPTORS, NEUROTENSIN; RNA, MESSENGER; STEREOTYPED BEHAVIOR; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 4444373758     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.06.061     Document Type: Article

References (50)

1. M.R. Adams, E.P. Brandon, E.H. Chartoff, R.L. Idzerda, D.M. Dorsa, and G.S. McKnight Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice Proc. Natl. Acad. Sci. U. S. A. 94 1997 12157 12161
2. M. Beauregard, A. Ferron, and L. Descarries Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study Neuroscience 47 1992 613 619
3. C. Betancur, R. Cabrera, E.R. de Kloet, D. Pelaprat, and W. Rostene Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine Neuropsychopharmacology 19 1998 322 332
4. C.D. Blaha, A. Coury, H.C. Fibiger, and A.G. Phillips Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis Neuroscience 34 1990 699 705
5. G.R. Breese, A.A. Baumeister, T.J. McCown, S.G. Emerick, G.D. Frye, K. Crotty, and R.A. Mueller Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine J. Pharmacol. Exp. Ther. 231 1984 343 354
6. J.S. Brog, and D.S. Zahm Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration Neuroscience 65 1995 71 86
7. P. Brun, R. Steinberg, G. Le Fur, and P. Soubrie Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens J. Neurochem. 64 1995 2073 2079
8. M.N. Castel, P. Morino, A. Dagerlind, and T. Hokfelt Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment Eur. J. Neurosci. 6 1994 646 656
9. J. Chabry, C. Labbe-Jullie, D. Gully, P. Kitabgi, J.P. Vincent, and J. Mazella Stable expression of the cloned rat brain neurotensin receptor into fibroblasts: binding properties, photoaffinity labeling, transduction mechanisms, and internalization J. Neurochem. 63 1994 19 27
10. E.H. Chartoff, B.T. Marck, A.M. Matsumoto, D.M. Dorsa, and R.D. Palmiter Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation Proc. Natl. Acad. Sci. U. S. A. 98 2001 10451 10456
11. I. Creese, and S.D. Iverson Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-OHDA Brain Res. 55 1973 369 382
12. K.T. Delle Donne, J. Chan, H. Boudin, D. Pelaprat, W. Rostene, and V.M. Pickel Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell Synapse 52 2004 176 187
13. P.R. Dobner, J. Fadel, N. Deitemeyer, R.E. Carraway, and A.Y. Deutch Neurotensin-deficient mice show altered responses to antipsychotic drugs Proc. Natl. Acad. Sci. U. S. A. 98 2001 8048 8053
14. P.R. Dobner, A.Y. Deutch, and J. Fadel Neurotensin: dual roles in psychostimulant and antipsychotic drug responses Life Sci. 73 2003 801 811
15. G.N. Ervin, L.S. Birkemo, C.B. Nemeroff, and A.J. Prange Jr. Neurotensin blocks certain amphetamine-induced behaviours Nature 291 1981 73 76
16. R.H. Farkas, S. Nakajima, and Y. Nakajima Neurotensin excites basal forebrain cholinergic neurons: ionic and signal-transduction mechanisms Proc. Natl. Acad. Sci. U. S. A. 91 1994 2853 2857
17. J. Feldon, and I. Weiner From an animal model of attentional deficit towards new insights into the pathophysiology of schizophrenia J. Psychiatr. Res. 26 1992 345 366
18. L. Ferraro, W.T. O'Connor, T. Antonelli, K. Fuxe, and S. Tanganelli Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat Eur. J. Neurosci. 9 1997 1838 1846
19. L. Ferraro, T. Antonelli, W.T. O'Connor, K. Fuxe, P. Soubrie, and S. Tanganelli The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop J. Neurosci. 18 1998 6977 6989
20. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press San Diego xxii p. [186] p. of plates pp
21. D. Gully, M. Canton, R. Boigegrain, F. Jeanjean, J.-C. Molimard, M. Poncelet, C. Gueudet, M. Heaulme, P. Soubrie, J.-P. Maffrand, W. Rostene, P. Kitagbi, and G.L. Fur Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor Proc. Natl. Acad. Sci. U. S. A. 90 1993 65 69
22. G.R. Hanson, and K.A. Keefe Dopamine D1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway Brain Res. Mol. Brain Res. 66 1999 111 121
23. S. Hernandez-Lopez, T. Tkatch, E. Perez-Garci, E. Galarraga, J. Bargas, H. Hamm, and D.J. Surmeier D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade J. Neurosci. 20 2000 8987 8995
24. O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function Pharmacol. Rev. 18 1966 925 964
25. L. Jennes, W.E. Stumpf, and P.W. Kalivas Neurotensin: topographical distribution in rat brain by immunohistochemistry J. Comp. Neurol. 210 1982 211 224
26. F.B. Jolicoeur, G. De Michele, A. Barbeau, and S. St-Pierre Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation Neurosci. Biobehav. Rev. 7 1983 385 390
27. P.W. Kalivas, S.K. Burgess, C.B. Nemeroff, and A.J. Prange Jr. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat Neuroscience 8 1983 495 505
28. P.W. Kalivas, and P. Duffy Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens J. Neurosci. 10 1990 2940 2949
29. J.W. Kebabian, G.L. Petzold, and P. Greengard Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor" Proc. Natl. Acad. Sci. U. S. A. 69 1972 2145 2149
30. D.S. Kim, M.S. Szczypka, and R.D. Palmiter Dopamine-deficient mice are hypersensitive to dopamine receptor agonists J. Neurosci. 20 2000 4405 4413
31. B. Kinkead, and C.B. Nemeroff Neurotensin: an endogenous antipsychotic? Curr. Opin. Pharmacol. 2 2002 99 103
32. E. Kislauskis, and P.R. Dobner Mutually dependent response elements in the cis-regulatory region of the neurotensin/neuromedin N gene integrate environmental stimuli in PC12 cells Neuron 4 1990 783 795
33. S.E. Leeman, and R.E. Carraway Neurotensin, discovery, isolation, characterization, synthesis, and possible physiological roles Ann. N.Y. Acad. Sci. 400 1982 1 16
34. M. Leonetti, P. Brun, M. Clerget, R. Steinberg, P. Soubrie, B. Renaud, and M.F. Suaud-Chagny Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice J. Neurochem. 89 2004 1 6
35. K.M. Merchant, M.A. Miller, E.A. Ashleigh, and D.M. Dorsa Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in the neostriatum of the rat brain Brain Res. 540 1991 311 314
36. K.M. Merchant, P.R. Dobner, and D.M. Dorsa Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum J. Neurosci. 12 1992 652 663
37. K.M. Merchant, D.J. Dobie, F.M. Filloux, M. Totzke, M. Aravagiri, and D.M. Dorsa Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions J. Pharmacol. Exp. Ther. 271 1994 460 471
38. E. Richelson, M. Boules, and P. Fredrickson Neurotensin agonists: possible drugs for treatment of psychostimulant abuse Life Sci. 73 2003 679 690
39. P.P. Rompre Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine Eur. J. Pharmacol. 328 1997 131 134
40. P.P. Rompre, S.M. Boye, and J. Moisan Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing Eur. J. Pharmacol. 341 1998 169 172
41. R. Snijders, N.R. Kramarcy, R.W. Hurd, C.B. Nemeroff, and A.J. Dunn Neurotensin induces catalepsy in mice Neuropharmacology 21 1982 465 468
42. R. Steinberg, P. Brun, M. Fournier, J. Souilhac, D. Rodier, G. Mons, J.P. Terranova, G. Le Fur, and P. Soubrie SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission Neuroscience 59 1994 921 929
43. M.S. Szczypka, Q.Y. Zhou, and R.D. Palmiter Dopamine-stimulated sexual behavior is testosterone dependent in mice Behav. Neurosci. 112 1998 1229 1235
44. M.S. Szczypka, M.A. Rainey, D.S. Kim, W.A. Alaynick, B.T. Marck, A.M. Matsumoto, and R.D. Palmiter Feeding behavior in dopamine-deficient mice Proc. Natl. Acad. Sci. U. S. A. 96 1999 12138 12143
45. U. Ungerstedt Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system Acta Physiol. Scand., Suppl. 367 1971 95 122
46. J.D. Wagstaff, L.G. Bush, J.W. Gibb, and G.R. Hanson Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity Brain Res. 665 1994 237 244
47. R.A. Wise Neurobiology of addiction Curr. Opin. Neurobiol. 6 1996 243 251
48. R.A. Wise, and P.P. Rompre Brain dopamine and reward Annu. Rev. Psychol. 40 1989 191 225
49. T. Wu, A. Li, and H.L. Wang Neurotensin increases the cationic conductance of rat substantia nigra dopaminergic neurons through the inositol 1,4,5-trisphosphate-calcium pathway Brain Res. 683 1995 242 250
50. Q.-Y. Zhou, and R.D. Palmiter Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic Cell 83 1995 1197 1209